Related Experiment Videos
Morphologic analyses of proteoglycans in rabbit corneal scars
C Cintron1, H I Covington, C L Kublin
1Eye Research Institute, Boston, Massachusetts 02114.
Investigative Ophthalmology & Visual Science
|September 1, 1990
Summary
Scar healing in the cornea involves changes in proteoglycans (PGs), specifically keratan sulfate (KS) and chondroitin sulfate (CS) glycosaminoglycans (GAGs). Scar tissue initially mimics fetal cornea development, later transitioning to adult patterns by two years.
Area of Science:
- Ophthalmology and Tissue Engineering
- Biochemistry of Extracellular Matrix
Background:
- Proteoglycans (PGs) are crucial components of the corneal extracellular matrix.
- Understanding PG changes during corneal scar healing is vital for regenerative medicine.
Purpose of the Study:
- To investigate the ultrastructural localization and chemical changes of PGs, specifically keratan sulfate (KS) and chondroitin sulfate (CS) glycosaminoglycans (GAGs), during corneal scar development and healing.
- To compare PG patterns in healing scars with those in normal developing and adult corneas.
Main Methods:
- Ultrastructural localization using cuprolinic blue dye (CBD) staining.
- Specific enzymatic digestion of KS and CS GAGs.
- High critical electrolyte concentration conditions for selective GAG staining.
- Biosynthetic labeling with 35SO4 to trace PG movement.
- Immunohistochemical analysis.
Main Results:
- Early scars (1 week) showed CS throughout, with some altered KS in the anterior stroma.
- By 2 weeks, scars contained abundant CS and chemically altered, newly synthesized low-sulfated KS, differing from adult GAGs.
- KS distribution and characteristics in healing scars initially resembled developing cornea, transitioning to adult patterns by 2 years.
Conclusions:
- Corneal scar healing recapitulates some developmental events of the normal cornea.
- Nonuniform distribution and altered chemical properties of GAGs in scar tissue result from PG migration and de novo synthesis.
- These findings offer insights into corneal tissue regeneration and potential therapeutic targets.